Skip to main content

MDL Court Frames Guidelines For Testing Asbestos In Talc

MDL Court Frames Guidelines For Testing Asbestos In Talc

MDL Court Frames Guidelines For Testing Asbestos In Talc

Introduction

On November 1, Special Master Joel Pisano, appointed by the U.S. District Judge Freda L. Wolfson presiding over all federal talcum powder lawsuits, approved a supplemental order with regards to the testing procedures for Johnson & Johnson's (J&J) Baby Powder samples from the recalled lots.

The order indicates that J&J should notify plaintiffs that additional samples for independent testing will not be available, if the testing associated with recent recall uses up all the samples. It further states to preserve the samples and recalled bottles of baby powder returned by consumers and an appropriate protocol for dividing and selecting such samples should be raised with the court.

The last month's recall impacted 33,000 bottles after the FDA found evidence of asbestos in a sample tested. The lawsuits are consolidated under multidistrict litigation MDL No. 2738 ( In Re: Johnson & Johnson Talcum Powder Products Marketing, Sales Practices, and Products Liability Litigation). Lawsuits are also pending in a coordinated California proceeding under Judicial Council Coordinated Proceeding No. 4877.

Johnson's Baby Powder, one of the most popular products containing talcum powder, is linked to increasing a woman's risk of ovarian cancer if she uses it regularly in the genital area. In a few cases, the cancer tissue was studied using an electron microscope and was found to have talc in it, which supported the claim that the cancer was caused by the body powder and increases the talc-related cancer risk.

Comments

Restricted HTML

  • Allowed HTML tags: <a href hreflang> <em> <strong> <cite> <blockquote cite> <code> <ul type> <ol start type> <li> <dl> <dt> <dd> <h2 id> <h3 id> <h4 id> <h5 id> <h6 id>
  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.

Latest News

Purdue, Sacklers Agree to $7.4B Opioid Settlement

Categories: Opioids

Purdue Pharma and its owners, the Sackler family, have agreed to a $7.4 billion settlement to resolve thousands of lawsuits accusing the…

Paraquat Trials Scheduled for October 2025 & April 2026

Categories: Paraquat

A U.S. District Judge overseeing thousands of federal

UGA College of Pharmacy Gets $1M+ to Fight Opioid Crisis

Categories: Opioids

Faculty from the University of Georgia’s College of Pharmacy have been awarded a nearly $1.2 million grant from the Georgia Opioid Crisis…

Get 5 Free Medical Record Reviews – No Risk, No Contracts!      
Only 10 firms will be accepted!

Valid until February 28, 2025.